Jeff Yass’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,300
| Closed | -$1.04M | – | 14139 |
|
|
2021
Q2 | $1.04M | Sell |
6,300
-2,800
| -31% | -$467K | ﹤0.01% | 7656 |
|
|
2021
Q1 | $1.4M | Buy |
9,100
+5,800
| +176% | +$788K | ﹤0.01% | 6850 |
|
|
2020
Q4 | $414K | Sell |
3,300
-2,500
| -43% | -$280K | ﹤0.01% | 8672 |
|
|
2020
Q3 | $588K | Sell |
5,800
-6,300
| -52% | -$642K | ﹤0.01% | 7334 |
|
|
2020
Q2 | $1.18M | Sell |
12,100
-14,900
| -55% | -$1.39M | ﹤0.01% | 5556 |
|
|
2020
Q1 | $2.24M | Buy |
27,000
+6,600
| +32% | +$644K | ﹤0.01% | 3773 |
|
|
2019
Q4 | $2.27M | Sell |
20,400
-27,200
| -57% | -$2.8M | ﹤0.01% | 4112 |
|
|
2019
Q3 | $4.72M | Sell |
47,600
-12,500
| -21% | -$1.24M | ﹤0.01% | 2808 |
|
|
2019
Q2 | $5.96M | Sell |
60,100
-41,200
| -41% | -$3.93M | ﹤0.01% | 2478 |
|
|
2019
Q1 | $11.2M | Buy |
101,300
+52,800
| +109% | +$5.52M | ﹤0.01% | 1640 |
|
|
2018
Q4 | $4.46M | Sell |
48,500
-6,500
| -12% | -$658K | ﹤0.01% | 2415 |
|
|
2018
Q3 | $6.06M | Buy |
55,000
+23,100
| +72% | +$2.41M | ﹤0.01% | 2450 |
|
|
2018
Q2 | $2.98M | Buy |
31,900
+17,700
| +125% | +$1.52M | ﹤0.01% | 3392 |
|
|
2018
Q1 | $1.18M | Buy |
14,200
+2,300
| +19% | +$204K | ﹤0.01% | 4913 |
|
|
2017
Q4 | $1.08M | Sell |
11,900
-10,200
| -46% | -$848K | ﹤0.01% | 5065 |
|
|
2017
Q3 | $1.68M | Sell |
22,100
-4,200
| -16% | -$317K | ﹤0.01% | 4230 |
|
|
2017
Q2 | $1.97M | Buy |
26,300
+13,400
| +104% | +$929K | ﹤0.01% | 3929 |
|
|
2017
Q1 | $841K | Sell |
12,900
-10,900
| -46% | -$642K | ﹤0.01% | 5493 |
|
|
2016
Q4 | $1.31M | Buy |
23,800
+7,600
| +47% | +$417K | ﹤0.01% | 4953 |
|
|
2016
Q3 | $915K | Sell |
16,200
-3,200
| -16% | -$157K | ﹤0.01% | 4970 |
|
|
2016
Q2 | $810K | Buy |
+19,400
| New | +$894K | ﹤0.01% | 5266 |
|
|
2016
Q1 | – | Sell |
-9,100
| Closed | -$412K | – | 9925 |
|
|
2015
Q4 | $412K | Buy |
9,100
+1,400
| +18% | +$58.8K | ﹤0.01% | 7133 |
|
|
2015
Q3 | $299K | Buy |
7,700
+700
| +10% | +$28K | ﹤0.01% | 8045 |
|
|
2015
Q2 | $254K | Buy |
+7,000
| New | +$221K | ﹤0.01% | 8849 |
|
Other funds holding PRAH
Jeff Yass's PRAH Position: Q3 2021 in Review
Jeff Yass sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 622,837 shares — an estimated $103M sold.
Jeff Yass first reported a position in PRAH in Q4 2014 and held it in 18 quarters. The position peaked at $103M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Jeff Yass reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Jeff Yass sold 622,837 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $103M.
- Jeff Yass first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 18 quarters.
- Jeff Yass's PRA Health Sciences, Inc. position peaked at $103M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.